Stock Taper
SCREENER COMPARE ANY 2 STOCKS
ALGS
ALIGOS THERAPEUTICS, INC.
NASDAQ
$6.91
▼ DOWN 2.26% (-0.16)

KEY STATISTICS

Market Cap$42.76 M
52w High$13.69
52w Low$3.98
Dividend Yield—
Frequency—
P/E-0.95
Volume39.06K
Shares Out.6.19M

COMPANY

LEADERSHIP

Lawrence Blatt
CHIEF EXECUTIVE
Lawrence Blatt

COMPENSATION 2026

Salary$651,718
Stock Awards$0
Incentive Plan Pay$371,479
All Other Comp.$19,042
Total$4,057,234

ABOUT

SECTOR
Healthcare
WENT PUBLIC
October 16, 2020
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
82

PRICE TARGET

Target High$20.00
Target Low$20.00
Target Median$20.00
Target Consensus$20.00

UPCOMING EARNINGS

DateNov 5, 2026
DayThursday
Rev. Est.$4.85M
NOV
5
THU

SPLIT RECORD

DATETYPERATIO
2024-08-19Reverse1:25

PRICE

$6.91 ▼ DOWN 2.26% (−$0.16)
OVERLAYS
$6.75$6.90$7.059:37 AM10:41 AM11:44 AM12:48 PM1:52 PM2:55 PM3:59 PM6.91

About Aligos Therapeutics, Inc.

https://www.aligos.com ↗

Aligos Therapeutics is a clinical-stage biotech developing novel therapies for viral and liver diseases, including hepatitis B and NASH, with multiple candidates in Phase I and Ib trials.

INDUSTRY

Biotechnology

A PRODUCT ALIGOS THERAPEUTICS, INC. IS KNOWN FOR

Pevifoscorvir sodium (ALG-000184)
Pevifoscorvir sodium (ALG-000184)

A Phase 2 oral small-molecule capsid assembly modulator developing the lead drug candidate to treat chronic hepatitis B, addressing a major unmet medical need in viral liver diseases.

COMPETITORS

COMPETITOR
ABUS COMPARE
ASMB COMPARE
GILD COMPARE
GSK COMPARE
VIR COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
16
LISTED HERE
4
RANKED BY POSITION SIZE
VTI
0.00% · 128.8K
IWC
0.01% · 16.6K
DFMC
0.00% · 8.3K
AVSC
0.00% · 1.4K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
96.57%
HOLDERS
54
TOP 12 OF 54 · RANKED BY POSITION SIZE
Altitude Crest Partners Inc.
2.8M sh · $2.79M
Woodline Partners LP
468.2K sh · $4.59M
Deep Track Capital, LP
444.1K sh · $3.3M
Alyeska Investment Group, L.P.
412.0K sh · $3.06M
Sio Capital Management, LLC
335.9K sh · $3.13M
Marshall Wace, Llp
268.7K sh · $2.5M
Bank Of America Corp /De/
229.8K sh · $1.71M
Blackrock Inc.
227.4K sh · $79.59K
Readystate Asset Management LP
203.1K sh · $1.99M
Vanguard Group Inc
200.4K sh · $1.87M
Indexiq Advisors LLC
193.0K sh · $415K
Summittx Capital, L.P.
148.8K sh · $1.11M

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity3
Price To Earnings1
Price To Book3
Overall Score2

INSIDER TRADES

★
DIRECTOR
Martell Bridget A
Purchase · 5.9K shares
2026-06-25
★
DIRECTOR
Scopa James Paul
Purchase · 5.9K shares
2026-06-25
★
DIRECTOR
Nuechterlein Carole
Purchase · 5.9K shares
2026-06-25
★
DIRECTOR
Hirth Peter
Purchase · 5.9K shares
2026-06-25

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 1
1 GRADES IN THE LAST 12 MONTHS
HC Wainwright & Co. BUY

SECTORS PEERS

PEERPRICE
XFOR$4.04COMPARE
OKUR$3.79COMPARE
INMB$2.33COMPARE
BRNS$0.75COMPARE
TPST$1.06COMPARE
SKYE$1.77COMPARE